Berman Capital Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $238K | Buy |
5,502
+1,673
| +44% | +$72.4K | 0.04% | 235 |
|
|
2021
Q2 | $163K | Buy |
3,829
+1,126
| +42% | +$47.9K | 0.03% | 272 |
|
|
2021
Q1 | $103K | Buy |
2,703
+569
| +27% | +$21.7K | 0.02% | 300 |
|
|
2020
Q4 | $76K | Sell |
2,134
-1,007
| -32% | -$35.9K | 0.02% | 306 |
|
|
2020
Q3 | $120K | Sell |
3,141
-1,003
| -24% | -$38.3K | 0.03% | 200 |
|
|
2020
Q2 | $144K | Buy |
4,144
+1,719
| +71% | +$59.7K | 0.04% | 178 |
|
|
2020
Q1 | $78K | Buy |
2,425
+316
| +15% | +$10.2K | 0.03% | 232 |
|
|
2019
Q4 | $95K | Sell |
2,109
-40
| -2% | -$1.8K | 0.03% | 225 |
|
|
2019
Q3 | $87K | Sell |
2,149
-121
| -5% | -$4.9K | 0.03% | 224 |
|
|
2019
Q2 | $97K | Buy |
2,270
+330
| +17% | +$14.1K | 0.03% | 210 |
|
|
2019
Q1 | $74K | Buy |
1,940
+703
| +57% | +$26.8K | 0.02% | 230 |
|
|
2018
Q4 | $42K | Buy |
+1,237
| New | +$42K | 0.02% | 269 |
|